- Home
- TLSI vs ZOM Comparison
TLSI vs ZOM Comparison
Compare TLSI & ZOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- ZOM
- Stock Information
- Founded
- TLSI 2010
- ZOM 2015
- Country
- TLSI United States
- ZOM United States
- Employees
- TLSI N/A
- ZOM N/A
- Industry
- TLSI Medical Specialities
- ZOM Biotechnology: Pharmaceutical Preparations
- Sector
- TLSI Health Care
- ZOM Health Care
- Exchange
- TLSI Nasdaq
- ZOM Nasdaq
- Market Cap
- TLSI 150.3M
- ZOM 128.4M
- IPO Year
- TLSI N/A
- ZOM N/A
- Fundamental
- Price
- TLSI $4.93
- ZOM $0.13
- Analyst Decision
- TLSI Strong Buy
- ZOM
- Analyst Count
- TLSI 6
- ZOM 0
- Target Price
- TLSI $11.75
- ZOM N/A
- AVG Volume (30 Days)
- TLSI 33.1K
- ZOM 8.2M
- Earning Date
- TLSI 11-14-2024
- ZOM 11-07-2024
- Dividend Yield
- TLSI N/A
- ZOM N/A
- EPS Growth
- TLSI N/A
- ZOM N/A
- EPS
- TLSI N/A
- ZOM N/A
- Revenue
- TLSI $26,891,000.00
- ZOM $26,727,000.00
- Revenue This Year
- TLSI $60.96
- ZOM $10.28
- Revenue Next Year
- TLSI $53.65
- ZOM $28.00
- P/E Ratio
- TLSI N/A
- ZOM N/A
- Revenue Growth
- TLSI 67.90
- ZOM 11.33
- 52 Week Low
- TLSI $3.50
- ZOM $0.12
- 52 Week High
- TLSI $10.42
- ZOM $0.20
- Technical
- Relative Strength Index (RSI)
- TLSI 56.22
- ZOM 50.93
- Support Level
- TLSI $4.53
- ZOM $0.13
- Resistance Level
- TLSI $4.92
- ZOM $0.16
- Average True Range (ATR)
- TLSI 0.29
- ZOM 0.01
- MACD
- TLSI -0.02
- ZOM -0.00
- Stochastic Oscillator
- TLSI 50.63
- ZOM 27.44
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ZOM Zomedica Corp.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.